PMH25 An Assessement of the Cost-Effectiveness of Escitalopram Versus Multiple Comparators as First Line Antidepressant in Patients With Major Depressive Disorder (MDD) in Belgium
Nov 1, 2012, 00:00
10.1016/j.jval.2012.08.815
https://www.valueinhealthjournal.com/article/S1098-3015(12)02528-4/fulltext
Title :
PMH25 An Assessement of the Cost-Effectiveness of Escitalopram Versus Multiple Comparators as First Line Antidepressant in Patients With Major Depressive Disorder (MDD) in Belgium
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)02528-4&doi=10.1016/j.jval.2012.08.815
First page :
A338
Section Title :
Mental Health
Open access? :
No
Section Order :
325